| Detected | Trial | Change |
|---|---|---|
| 2026-07-23 | NCT07551804 Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults… |
Recruitment opened |
| 2026-07-23 | NCT07614152 The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-03 | NCT07741461 ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB) | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06927310 | The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short… | Idiopathic Short Stature | Recruiting |
| NCT07309562 | The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born… | Small for Gestational Age | Recruiting |
| NCT07614152 | The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome… | Turner Syndrome | Recruiting |
| Phase 2 | |||
| NCT06552429 | Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET | Essential Thrombocythemia | Recruiting |
| NCT07551804 | Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults… | Adult Growth Hormone Deficiency | Recruiting |
| Phase 1 | |||
| NCT07408908 | Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in… | Systemic Lupus Erythematosus | Not Yet Recruiting |
| NCT07462455 | Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in… | Metabolic Dysfunction-associated Steatohepatitis | Not Yet Recruiting |
| NCT07589400 | Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in… | Metabolic Dysfunction-associated Steatotic Liver Disease | Not Yet Recruiting |
| NCT07741461 | ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB) | Chronic Hepaititis B | Not Yet Recruiting |
| Not specified | |||
| NCT06707922 | A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic… | Chronic Hepatitis B | Enrolling by Invitation |